Get the training you need in a self-paced, convenient format with a course specifically designed for APNs to meet the Drug Enforcement Administration (DEA)'s new requirement under the Medication Access and Training Expansion (MATE) Act
Starting June 27, 2023, renewing DEA-registered practitioners must complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders
For Advanced Practice Nurses
›
8 hours
95
Satisfies mandatory DEA requirements in:
Opioids or other substance use disorders
ANCC-accredited provider
Includes your DEA-required training!
+ 8-hour DEA-required training
Satisfy your DEA-required training
All State-Required CE
All of the RN or LPN state-required CE you need, no matter where you practice
Prescribing Controlled Substances Safely - A DEA Requirement 8-hour course is included
Unlimited Podcast CE Access
Extensive CE Library
Unlimited CE credit for listening to Elite CE podcasts on apps like Apple, Spotify & YouTube
Choose from a library of 250+ courses, including pharmacology courses
CE designed to help nurses at all stages of professional development to acquire knowledge and skills while satisfying mandatory requirements for license renewal
Get Started Now
What is the new DEA substance use training requirement?
A part of the Consolidated Appropriations Act of 2023 passed by the DEA on December 29, 2022, this one-time requirement is for APNs and other DEA-registered clinicians to complete eight hours of training on the treatment and management of patients with opioid or other substance use disorders.
Who is impacted by this new DEA requirement?
All DEA-registered registered practitioners, with the exception of those who are solely veterinarians, are responsible for completing the requirement.
When is the deadline for meeting this new requirement?
Practitioners will begin to report completion of the requirement on their DEA registration or regularly-scheduled registration renewal form starting on or after June 27, 2023. This will require practitioners to check a box on their DEA registration form confirming that they have completed the 8 hour substance use training requirement.
Can Elite help me meet the DEA substance use disorder requirement?
Yes! APNs can purchase and complete the Prescribing Controlled Substances Safety - A DEA Requirement course, which is an 8-hour, self-paced course that fulfills the requirement once completed.
Where can I find more information about the new DEA requirement?
You can find additional information about the new requirement in the official letter released by the DEA.
Behind each course is a team of experts with one goal: developing top-notch dental CE to help you deliver quality care.
Complete your CE with the confidence that our nursing courses are from an ANCC-certified provider and accepted by state boards
Evidence-based content, practical application and courses delivered in a flexible platform that goes with you wherever you are.
Copyright © 2023 Elite Learning. All rights reserved.
About the Course
Nurse Practitioners (NPs), Physician Assistants (PAs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
Learning Outcomes